All posts by: Michael Zand

About Michael Zand

Myeloid derived suppressor cells provide niche where cancer stem cells survive – News-Medical.net

News-Medical.netThe immune system is normally known for protecting the body from illness. But a subset of immune cells appear to be doing more harm than good. A new study from researchers at the University of Michigan Comprehensive Cancer Center found that these …Some immune cells appear to aid cancer cell growth, study findsMedical XpressSome Immune … Continue reading

2013-09-06 NEWS

Novartis signs deal to boost cell therapy portfolio – Reuters

ReutersThe maker of blockbuster blood pressure drug Diovan said it would use a stem–cell based platform developed by U.S.-based biopharmaceutical company Regenerex to help broaden its cell therapy portfolio. Timothy Wright, head of development at Novartis …Novartis signs cell therapy deal with RegenerexPMLiVENovartis announces an exclusive global licensing and research collaboration …ITNews all 5 news … Continue reading

2013-09-06 NEWS

First patient treated in groundbreaking stem cell therapy trial for heart attack – HealthCanal.com

First patient treated in groundbreaking stem cell therapy trial for heart attackHealthCanal.comThis experimental therapy uses the patient’s own stem cells extracted from their blood soon after a major heart attack. These cells are enhanced in the laboratory with the insertion of a gene called endothelial nitric oxide synthase, which stimulates … …read more   &nbs… Continue reading

2013-09-05 NEWS